Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker NCDL
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 10, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jul 10, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 28, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 20, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 26, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Feb 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 4, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 4, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 8, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 8, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 28, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 26, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Mar 26, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 10, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 27, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 27, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 14, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 29, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 22, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 22, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 15, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 15, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 7, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 7, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
35 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances